To improve the synergy between SMC and OVs even further, OVs have been armed with exogenous tumor cell death enhancing (TCDE) cytokines, like TNF-α [186], which also addresses toxicity issues commonly associated with their systemic delivery. This evidence concerns the gene TNF and neoplasm.